Back to Journals » Drug Design, Development and Therapy » Volume 16 » Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
Please verify you are not a robot.
Back to Journals » Drug Design, Development and Therapy » Volume 16 » Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway
Please verify you are not a robot.